US Edition
Moderna inks five-year Mexico deal as it pushes geographic expansion to hit breakeven
- Mexico's Health Ministry and Moderna signed an agreement for vaccine production and scientific research in Mexico, announced by President Claudia Sheinbaum from the National Palace in Mexico City.
- The agreement includes producing various vaccines, with joint research on developing vaccines for COVID-19, dengue, and cancer, involving Mexican researchers.
- Moderna's CEO St�phane Bancel stated that the agreement aims to enhance Mexico's health sovereignty and security, providing access to respiratory vaccines.
- Moderna will collaborate on clinical research and strengthen pandemic preparedness as part of Mexico's initiative to increase local production capacity.
13 Articles
13 Articles
Mexico to produce mRNA vaccines under new agreement with Moderna
Mexico’s Health Ministry, state-owned medical company Birmex, Mexican pharmaceutical company Liomont and U.S. pharmaceutical firm Moderna have signed an agreement to collaborate on vaccine production in Mexico and related scientific research. President Claudia Sheinbaum announced the pact in a video that was filmed at the National Palace in Mexico City and posted to social media on Monday night. “Today is a very important day for our country,” s…
President Claudia Sheinbaum reported last night on the signing of a collaboration agreement between the pharmaceutical laboratories Moderna, of the United States; Liomont, of Mexico, and Laboratories of Biologicals and Reagents of Mexico (Birmex) for the production of vaccines with messenger RNA technology. With this, she said, the goal of making the country a scientific power of knowledge will be met.
President Claudia Sheinbaum Pardo acknowledged that the Patria vaccine faced "some problems" in its production, after signing an agreement with Moderna, Birmex and Liomont to make vaccines for...
Coverage Details
Bias Distribution
- 60% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
